Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity

Breast Cancer Research

Volumn 6, Issue 4, 2004, Pages

  Azmy, Iman AF ^a   Balasubramanian, Saba P ^a   Wilson, Anthony G ^a   Stephenson, Timothy J ^a   Cox, Angela ^a   Brown, Nicola J ^a   Reed, Malcolm WR ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

breast cancer; genetic polymorphisms; tumour necrosis factor; vascular invasion

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7044229734     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr802     Document Type: Article

References (36)

1. M.H. Greene Genetics of breast cancer Mayo Clin Proc 1997 72 54 65 1:CAS:528:DyaK2sXksFOgsg%3D%3D 10.4065/72.1.54 9005288
2. A.M. Dunning C.S. Healey P.D. Pharoah M.D. Teare B.A. Ponder D.F. Easton A systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 1999 8 843 854 1:CAS:528:DyaK1MXns1CrtLw%3D 10548311
3. S.S. Coughlin M. Piper Genetic polymorphisms and risk of breast cancer Cancer Epidemiol Biomarkers Prev 1999 8 1023 1032 1:CAS:528:DyaK1MXnvVGmurw%3D 10566559
4. B.L. Weber K.L. Nathanson Low penetrance genes associated with increased risk for breast cancer Eur J Cancer 2000 36 1193 1199 1:CAS:528:DC%2BD3cXksFCrsr8%3D 10.1016/S0959-8049(00)00082-4 10882856
5. F. Bazzoni B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 1996 334 1717 1725 1:CAS:528:DyaK28XksVOmsb4%3D 10.1056/NEJM199606273342607 8637518
6. B. Beutler A. Cerami The biology of cachectin/TNF – a primary mediator of the host response Annu Rev Immunol 1989 7 625 655 1:CAS:528:DyaL1MXit12ltro%3D 10.1146/annurev.iy.07.040189.003205 2540776
7. M. Jaattela Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin Lab Invest 1991 64 724 742 1:CAS:528:DyaK3MXmsFentLw%3D 1646350
8. A. Komori J. Yatsunami M. Suganuma S. Okabe S. Abe A. Sakai K. Sasaki H. Fujiki Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation Cancer Res 1993 53 1982 1985 1:CAS:528:DyaK3sXktVKqt7k%3D 8481899
9. H. Fujiki M. Suganuma Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid J Biochem (Tokyo) 1994 115 1 5 1:CAS:528:DyaK2cXpvVGgtA%3D%3D
10. H. Fujiki M. Suganuma A. Komori J. Yatsunami S. Okabe T. Ohta E. Sueoka A new tumor promotion pathway and its inhibitors Cancer Detect Prev 1994 18 1 7 1:CAS:528:DyaK2cXitFSjurY%3D 8162603
11. M. Suganuma S. Okabe M.W. Marino A. Sakai E. Sueoka H. Fujiki Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice Cancer Res 1999 59 4516 4518 1:CAS:528:DyaK1MXmtVKksLs%3D 10493498
12. K. Warzocha G. Salles J. Bienvenu Y. Bastion C. Dumontet N. Renard E.M. Neidhardt-Berard B. Coiffier Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J Clin Oncol 1997 15 499 508 1:STN:280:DyaK2s7nvVOgug%3D%3D 9053471
13. J. Nakashima M. Tachibana M. Ueno A. Miyajima S. Baba M. Murai Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer Clin Cancer Res 1998 4 1743 1748 1:CAS:528:DyaK1cXks1KitLg%3D 9676850
14. R.D. Leek R. Landers S.B. Fox F. Ng A.L. Harris C.E. Lewis Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma Br J Cancer 1998 77 2246 2251 1:STN:280:DyaK1czhtFCktg%3D%3D 10.1038/bjc.1998.373 9649140 2150409
15. M. Ioculano D. Altavilla F. Squadrito P. Canale G. Squadrito A. Saitta G.M. Campo A.P. Caputi Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury Pharmacol Res 1995 31 281 288 1:CAS:528:DyaK2MXntlShs74%3D 10.1016/1043-6618(95)80033-6 7479525
16. A.H. Hajeer I.V. Hutchinson Influence of TNFalpha gene polymorphisms on TNFalpha production and disease Hum Immunol 2001 62 1191 1199 1:CAS:528:DC%2BD3MXotFSlsrw%3D 10.1016/S0198-8859(01)00322-6 11704281
17. G. Bouma B. Xia J.B. Crusius G. Bioque I. Koutroubakis B.M. Von Blomberg S.G. Meuwissen A.S. Pena Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD) Clin Exp Immunol 1996 103 391 396 1:CAS:528:DyaK28XisF2jtbs%3D 10.1111/j.1365-2249.1996.tb08292.x 8608636 2200378
18. E. Louis D. Franchimont A. Piron Y. Gevaert N. Schaaf-Lafontaine S. Roland P. Mahieu M. Malaise D. De Groote R. Louis J. Belaiche Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans Clin Exp Immunol 1998 113 401 406 1:CAS:528:DyaK1cXmsVOls7w%3D 10.1046/j.1365-2249.1998.00662.x 9737669 1905064
19. A.G. Wilson J.A. Symons T.L. McDowell H.O. McDevitt G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci USA 1997 94 3195 3199 1:CAS:528:DyaK2sXisVKgtbg%3D 10.1073/pnas.94.7.3195 9096369 20345
20. T.W. Huizinga R.G. Westendorp E.L. Bollen V. Keijsers B.M. Brinkman J.A. Langermans F.C. Breedveld C.L. Verweij L. van de Gaer L. Dams J.B. Crusius A. Garcia-Gonzalez B.W. van Oosten C.H. Polman A.S. Pena TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients J Neuroimmunol 1997 72 149 153 1:CAS:528:DyaK2sXhslanug%3D%3D 10.1016/S0165-5728(96)00182-8 9042107
21. L. Chouchane S.B. Ahmed S. Baccouche S. Remadi Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors Cancer 1997 80 1489 1496 1:CAS:528:DyaK2sXmvFyhtbY%3D 10.1002/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1 9338474
22. S. Mestiri N. Bouaouina S.B. Ahmed A. Khedhaier B.B. Jrad S. Remadi L. Chouchane Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma Cancer 2001 91 672 678 1:CAS:528:DC%2BD3MXhsFCrt7c%3D 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J 11241233
23. K.S. Park J.W. Mok H.E. Ko K. Tokunaga M.H. Lee Polymorphisms of tumour necrosis factors A and B in breast cancer Eur J Immunogenet 2002 29 7 10 1:CAS:528:DC%2BD38Xit1Wltb8%3D 10.1046/j.0960-7420.2001.00260.x 11841482
24. W.H. Jang Y.I. Yang S.S. Yea Y.J. Lee J.H. Chun H.I. Kim M.S. Kim K.H. Paik The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers Cancer Lett 2001 166 41 46 1:CAS:528:DC%2BD3MXisVaksr8%3D 10.1016/S0304-3835(01)00438-4 11295285
25. F.S. di Giovine N.J. Camp A. Cox A.G. Chaudhary J.A. Sorrell A. Crane G.W. Duff Detection and Population Analysis of IL-1 and TNF Gene Polymorphisms 2000 Oxford Oxford University Press
26. A.K. Daly C.P. Day Candidate gene case–control association studies: advantages and potential pitfalls Br J Clin Pharmacol 2001 52 489 499 1:STN:280:DC%2BD3MnovFGmsg%3D%3D 10.1046/j.0306-5251.2001.01510.x 11736857 2014606
27. T.V. Perneger What's wrong with Bonferroni adjustments Br Med J 1998 316 1236 1238 1:STN:280:DyaK1c3itFSmtg%3D%3D 10.1136/bmj.316.7139.1236
28. S. Yoshida M. Ono T. Shono H. Izumi T. Ishibashi H. Suzuki M. Kuwano Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis Mol Cell Biol 1997 17 4015 4023 1:CAS:528:DyaK2sXktFOisrg%3D 10.1128/MCB.17.7.4015 9199336 232254
29. E.A. Philp T.J. Stephenson M.W. Reed Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder Br J Urol 1996 77 352 357 1:STN:280:DyaK283kslWhtA%3D%3D 10.1046/j.1464-410X.1996.08475.x 8814837
30. F. Balkwill Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002 13 135 141 1:CAS:528:DC%2BD38XitFWhsrY%3D 10.1016/S1359-6101(01)00020-X 11900989
31. S.T. Malik D.B. Griffin W. Fiers F.R. Balkwill Paradoxical effects of tumour necrosis factor in experimental ovarian cancer Int J Cancer 1989 44 918 925 1:CAS:528:DyaK3cXhvFOrsg%3D%3D 10.1002/ijc.2910440529 2583871
32. S.T. Malik M.S. Naylor N. East A. Oliff F.R. Balkwill Cells secreting tumour necrosis factor show enhanced metastasis in nude mice Eur J Cancer 1990 26 1031 1034 1:CAS:528:DyaK3MXisVGkt7w%3D 10.1016/0277-5379(90)90044-T 2148875
33. H. Okahara H. Yagita K. Miyake K. Okumura Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis Cancer Res 1994 54 3233 3236 1:CAS:528:DyaK2cXktlaqsLo%3D 7515767
34. P. Orosz A. Kruger M. Hubbe J. Ruschoff P. Von Hoegen D.N. Mannel Promotion of experimental liver metastasis by tumor necrosis factor Int J Cancer 1995 60 867 871 1:CAS:528:DyaK2MXls1KnsbY%3D 10.1002/ijc.2910600624 7896459
35. S.P. Balasubramanian N.J. Brown M.W. Reed Role of genetic polymorphisms in tumour angiogenesis Br J Cancer 2002 87 1057 1065 1:CAS:528:DC%2BD38XotFWru7s%3D 10.1038/sj.bjc.6600625 12402142 2376194
36. S.P. Balasubramanian A. Cox A.G. Wilson N.J. Brown M.W. Reed Endostatin polymorphism in breast cancer Eur J Surg Oncol 2002 28 786 [Abstract] 10.1053/ejso.2001.1155